A detailed history of Thrivent Financial For Lutherans transactions in West Pharmaceutical Services Inc stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 18,738 shares of WST stock, worth $6.26 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
18,738
Previous 11,404 64.31%
Holding current value
$6.26 Million
Previous $3.76 Million 49.76%
% of portfolio
0.01%
Previous 0.01%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 07, 2024

BUY
$277.16 - $333.3 $2.03 Million - $2.44 Million
7,334 Added 64.31%
18,738 $5.63 Million
Q2 2024

Aug 13, 2024

SELL
$314.68 - $395.94 $1.12 Million - $1.4 Million
-3,544 Reduced 23.71%
11,404 $3.76 Million
Q1 2024

May 14, 2024

SELL
$338.27 - $413.0 $19,281 - $23,541
-57 Reduced 0.38%
14,948 $5.92 Million
Q4 2023

Feb 14, 2024

SELL
$318.29 - $392.21 $289,643 - $356,911
-910 Reduced 5.72%
15,005 $5.28 Million
Q3 2023

Nov 14, 2023

BUY
$354.9 - $412.41 $712,284 - $827,706
2,007 Added 14.43%
15,915 $5.97 Million
Q2 2023

Aug 14, 2023

BUY
$334.63 - $382.47 $3.55 Million - $4.05 Million
10,594 Added 319.67%
13,908 $5.32 Million
Q1 2023

May 17, 2023

BUY
$232.5 - $346.47 $1,627 - $2,425
7 Added 0.21%
3,314 $1.15 Million
Q4 2022

Feb 08, 2023

BUY
$209.34 - $261.61 $2,721 - $3,400
13 Added 0.39%
3,307 $778,000
Q3 2022

Nov 14, 2022

SELL
$246.08 - $343.65 $383,146 - $535,063
-1,557 Reduced 32.1%
3,294 $811,000
Q2 2022

Aug 16, 2022

SELL
$280.61 - $420.45 $33,953 - $50,874
-121 Reduced 2.43%
4,851 $1.47 Million
Q1 2022

May 13, 2022

SELL
$357.49 - $445.92 $3.66 Million - $4.57 Million
-10,247 Reduced 67.33%
4,972 $2.04 Million
Q4 2021

Feb 16, 2022

BUY
$402.25 - $471.34 $4.21 Million - $4.93 Million
10,454 Added 219.39%
15,219 $6.97 Million
Q3 2021

Nov 15, 2021

BUY
$363.01 - $468.47 $8,349 - $10,774
23 Added 0.49%
4,765 $2.02 Million
Q2 2021

Sep 24, 2021

BUY
$284.77 - $363.2 $430,002 - $548,432
1,510 Added 46.72%
4,742 $1.7 Million
Q2 2021

Aug 19, 2021

SELL
$284.77 - $363.2 $725,593 - $925,433
-2,548 Reduced 44.08%
3,232 $1.16 Million
Q1 2021

May 17, 2021

SELL
$257.29 - $307.53 $10 Million - $11.9 Million
-38,856 Reduced 87.05%
5,780 $1.63 Million
Q4 2020

Feb 16, 2021

BUY
$261.16 - $301.66 $9.5 Million - $11 Million
36,364 Added 439.6%
44,636 $12.6 Million
Q3 2020

Nov 10, 2020

SELL
$224.99 - $288.02 $41,848 - $53,571
-186 Reduced 2.2%
8,272 $2.27 Million
Q2 2020

Aug 12, 2020

SELL
$149.8 - $227.17 $5.84 Million - $8.86 Million
-38,991 Reduced 82.17%
8,458 $1.92 Million
Q1 2020

May 15, 2020

SELL
$128.96 - $174.76 $3.04 Million - $4.12 Million
-23,559 Reduced 33.18%
47,449 $7.22 Million
Q4 2019

Feb 13, 2020

BUY
$137.6 - $151.21 $4.23 Million - $4.65 Million
30,736 Added 76.32%
71,008 $10.7 Million
Q3 2019

Nov 14, 2019

SELL
$121.41 - $150.02 $9.69 Million - $12 Million
-79,834 Reduced 66.47%
40,272 $5.71 Million
Q2 2019

Aug 13, 2019

SELL
$111.27 - $125.15 $4.71 Million - $5.3 Million
-42,362 Reduced 26.07%
120,106 $15 Million
Q1 2019

May 14, 2019

BUY
$94.53 - $110.2 $91,883 - $107,114
972 Added 0.6%
162,468 $17.9 Million
Q4 2018

Feb 15, 2019

BUY
$93.0 - $123.98 $1.47 Million - $1.97 Million
15,857 Added 10.89%
161,496 $15.8 Million
Q3 2018

Nov 15, 2018

BUY
$98.01 - $123.47 $591,686 - $745,388
6,037 Added 4.32%
145,639 $18 Million
Q2 2018

Aug 14, 2018

BUY
$83.32 - $101.88 $131,812 - $161,174
1,582 Added 1.15%
139,602 $13.9 Million
Q1 2018

May 08, 2018

BUY
$85.56 - $102.4 $78,372 - $93,798
916 Added 0.67%
138,020 $12.2 Million
Q4 2017

Feb 14, 2018

SELL
$91.65 - $101.65 $10,448 - $11,588
-114 Reduced 0.08%
137,104 $13.5 Million
Q3 2017

Nov 14, 2017

BUY
$84.54 - $96.75 $11.6 Million - $13.3 Million
137,218
137,218 $13.2 Million

Others Institutions Holding WST

About WEST PHARMACEUTICAL SERVICES INC


  • Ticker WST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 74,033,000
  • Market Cap $24.7B
  • Description
  • West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers sto...
More about WST
Track This Portfolio

Track Thrivent Financial For Lutherans Portfolio

Follow Thrivent Financial For Lutherans and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.